“Transthyretin Silencing Therapies and the Cardiology Clinic: Selection, Cost and the Diagnostic Bottleneck Upstream” (2023) Journal of Heart and Cardiovascular Science, 4(1), pp. 1–4. doi:10.5281/zenodo.22345291.